Amplia Therapeutics: An oral cancer drug trial with serious results!   Listen to ASX-listed Amplia Therapeutics Managing Director Chris Burns talk to Matt Birney on the Bulls N’ Bears Report about Amplia’s remarkable drug that looks to be having an impact on a known cancer growth protein. See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

Amplia Therapeutics: An oral cancer drug trial with serious results! Listen to ASX-listed Amplia Therapeutics Managing Director Chris Burns talk to Matt Birney on the Bulls N’ Bears Report about Amplia’s remarkable drug that looks to be having an impact on a known cancer growth protein. See omnystudio.com/listener for privacy information.

Amplia Therapeutics: An oral cancer drug trial with serious results! &nbsp; Listen to ASX-listed Amplia Therapeutics Managing Director Chris Burns talk to Matt Birney on the Bulls N’ Bears Report about Amplia’s remarkable drug that looks to be having an impact on a known cancer growth protein.&nbsp;See <a href="https://omnystudio.com/listener" rel="noopener noreferrer">omnystudio.com/listener</a> for privacy information.

Amplia Therapeutics: An oral cancer drug trial with serious results!

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Business

Investing

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Share Amplia Therapeutics: An oral cancer drug trial with serious results!

Sign up to save your podcasts

Amplia Therapeutics: An oral cancer drug trial with serious results!

Amplia Therapeutics: An oral cancer drug trial with serious results!

More shows like Bulls N' Bears with Matt Birney

AFL Trade Radio

NAB Morning Call

Equity Mates Investing Podcast

Australian Investors Podcast

Money of Mine

The Explorers Podcast with Barry FitzGerald

Buy Hold Sell, by Livewire Markets

The Call from ausbiz

Market Updates

Footy Classified